Why is there still no FDA-approved testosterone for women?

What you will learn

• Why no female testosterone product has cleared the FDA
• What "off-label" actually means for you
• Why this topic gets so much attention online
• What FDA-approved options for low desire do exist
• The questions to ask before you start anything

The body of evidence is narrower than the headlines suggest. Research supports a testosterone trial for one specific issue in one specific group: hypoactive sexual desire disorder (HSDD) in postmenopausal women ¹. Outside of that, the data thin out fast. That narrow window is a big reason no company has won an FDA approval.

The gap is not an oversight. It is the result of a high bar, a narrow proven use, and trials that have not yet cleared it. A female testosterone product would need to show clear benefit and long-term safety for women specifically. So far, no sponsor has carried one all the way through.

A few reasons the approval gap persists:

• The proven use is narrow. Strong evidence centers on postmenopausal HSDD, not energy, mood, or weight.
• Safety data for women is limited. Safety data for testosterone at physiologic doses does not extend beyond 24 months of treatment ¹.
• The market math is hard. Past female products stalled in development, so sponsors hesitate.

The 2019 Global Consensus Position Statement on testosterone for women is the reference most clinicians use. It was endorsed by a group of medical societies that included The North American Menopause Society, now The Menopause Society. It calls postmenopausal HSDD the only evidence-based use, says an approved male formulation used off-label is reasonable when no approved female product is available and levels stay in the female range, and finds insufficient data to support testosterone for any other symptom ¹.

Off-label is not a loophole or a red flag by itself. It means a clinician is prescribing an FDA-approved product for a use the FDA has not specifically approved. This is legal and common across medicine. The catch: with no female product, dosing is a clinical decision, not a label instruction.

What that means in practice:

• You are using a male product at a much lower amount, set by a clinician.
• There is no standardized female dose printed on a box.
• Monitoring matters. The consensus statement calls for checking your response and your testosterone level to screen for overuse ¹.

The attention is new even if the science is not. "There is no FDA-approved testosterone for women" is a line that travels fast on social media. The frustration behind it is real for women who feel their symptoms have been brushed aside, and that gap is exactly where loud, oversimplified takes rush in.

Naming a real gap is useful. The risk is the leap from "this is under-studied and under-prescribed" to "everyone needs it." Those are not the same claim. No single creator, book, or post replaces an evaluation with a clinician who knows your history.

Here is the standard worth demanding. A good women's health provider does not hand out testosterone because a feed told you to ask. It evaluates your actual symptoms, walks you through FDA-approved options first, and only considers an off-label trial when the evidence fits your situation. Then it monitors you and adjusts.

It is also honest about money. Before you enter a card, a good provider shows you this: full cost disclosed before checkout. Recurring monthly charge until canceled. Cancel anytime in your account. No phone call required. If a brand will not state those terms plainly, that tells you something. This is the standard sipra is built around.

1. Write down the symptom that bothers you most, in plain words, before any appointment.
2. Ask which FDA-approved options fit you first, then whether an off-label trial makes sense for your history.
3. Demand the standard above: real evaluation, options laid out, full cost shown up front, and follow-up.

You deserve a clinician who reads your history, not your feed. That is where the real answer starts.

For more, see the broader guide to testosterone for women and the explainer on FDA-approved options for low desire.